Oral Unit Dosage Form Of Ivermectin
AssigneeChemo Research, S.L.
InventorsCarlos Lanusse, Alejandro Krolewiecki
Life of this patent
Estimating the term…
Abstract
The present invention discloses an oral solid unit dosage form comprising an amount of 3 to 25 mg ivermectin in at least one pharmaceutically acceptable excipient, and a method of treating subjects by administering an oral solid unit dosage form comprising an amount of 3 to 25 mg ivermectin in at least one pharmaceutically acceptable carrier.
Claims20
An oral solid unit dosage form comprising an amount of 3 to 25 mg ivermectin or a pharmaceutically acceptable salt or solvate thereof in at least one pharmaceutically acceptable excipient.
A method of treating subjects suffering from a coronavirus-associated disease by administering an oral solid unit dosage form comprising an amount of 3 to 25 mg ivermectin or a pharmaceutically acceptable salt or solvate thereof in at least one pharmaceutically acceptable carrier.
A method of treating subjects suffering from a coronavirus-associated disease by administering an oral solid unit dosage form comprising ivermectin or a pharmaceutically acceptable salt or solvate thereof in at least one pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.